Your browser doesn't support javascript.
loading
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.
Serra, Angela; Fratello, Michele; Federico, Antonio; Ojha, Ravi; Provenzani, Riccardo; Tasnadi, Ervin; Cattelani, Luca; Del Giudice, Giusy; Kinaret, Pia A S; Saarimäki, Laura A; Pavel, Alisa; Kuivanen, Suvi; Cerullo, Vincenzo; Vapalahti, Olli; Horvath, Peter; Lieto, Antonio Di; Yli-Kauhaluoma, Jari; Balistreri, Giuseppe; Greco, Dario.
Afiliación
  • Serra A; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Fratello M; BioMediTech Institute, Tampere University, Tampere, Finland.
  • Federico A; Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • Ojha R; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Provenzani R; BioMediTech Institute, Tampere University, Tampere, Finland.
  • Tasnadi E; Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • Cattelani L; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Del Giudice G; BioMediTech Institute, Tampere University, Tampere, Finland.
  • Kinaret PAS; Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • Saarimäki LA; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Pavel A; Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Kuivanen S; Synthetic and Systems Biology Unit, Biological Research Centre, Eotvos Lorand Research Network, Szeged, Hungary.
  • Cerullo V; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Vapalahti O; BioMediTech Institute, Tampere University, Tampere, Finland.
  • Horvath P; Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • Lieto AD; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Yli-Kauhaluoma J; BioMediTech Institute, Tampere University, Tampere, Finland.
  • Balistreri G; Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • Greco D; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Brief Bioinform ; 23(1)2022 01 17.
Article en En | MEDLINE | ID: mdl-34962256
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Pirimidinas / Células Gigantes / Estaurosporina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Brief Bioinform Asunto de la revista: BIOLOGIA / INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Pirimidinas / Células Gigantes / Estaurosporina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Brief Bioinform Asunto de la revista: BIOLOGIA / INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido